Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome

被引:96
作者
DeLeve, LD
Ito, Y
Bethea, NW
McCuskey, MK
Wang, XD
McCuskey, RS
机构
[1] Univ So Calif, Div Gastrointestinal & Liver Dis, Keck Sch Med, Los Angeles, CA 90033 USA
[2] Univ So Calif, Res Ctr Liver Dis, Keck Sch Med, Los Angeles, CA 90033 USA
[3] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2003年 / 284卷 / 06期
关键词
endothelium; hepatitis; toxic; glutathione; pyrrolizidine alkaloid;
D O I
10.1152/ajpgi.00526.2002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mechanisms leading to the obstruction of the microcirculation in sinusoidal obstruction syndrome ( SOS) have been unclear. Because this occurs at the onset of disease, this is a potential key target for therapeutic intervention. Rats were treated with monocrotaline with or without continuous intraportal infusion of glutathione and were studied at 0.5, 1, 2, 4, 6, and 10 days after monocrotaline treatment with the use of in vivo microscopy and transmission electron microscopy. Sinusoidal perfusion decreased from days 1 through 10 with a nadir on day 4. At 12 h, numerous swollen sinusoidal endothelial cells (SECs) were observed. Subsequently, red blood cells penetrated into the space of Disse through gaps between and through swollen SEC and dissected the sinusoidal lining away from the parenchymal cells. Sinusoidal blood flow was obstructed by an embolism of aggregates of sinusoidal lining cells, red blood cells, and adherent monocytes. All changes were prevented by glutathione infusion, notably the initial swelling of SEC. SOS is initiated by changes in SEC. Microcirculatory obstruction is due to dissection of the sinusoidal lining, followed by embolization of the sinusoid by sinusoidal lining cells, compounded by aggregates of monocytes adherent in the sinusoids. Glutathione prevents SOS by preserving an intact sinusoidal barrier.
引用
收藏
页码:G1045 / G1052
页数:8
相关论文
共 16 条
[1]  
ALLEN JR, 1969, ARCH PATHOL, V87, P279
[2]   THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION [J].
BEARMAN, SI .
BLOOD, 1995, 85 (11) :3005-3020
[3]  
Cai T, 1999, LAB INVEST, V79, P1151
[4]   Characterization of a reproducible rat model of hepatic veno-occlusive disease [J].
DeLeve, LD ;
McCuskey, RS ;
Wang, XD ;
Hu, LP ;
McCuskey, MK ;
Epstein, RB ;
Kanel, GC .
HEPATOLOGY, 1999, 29 (06) :1779-1791
[5]   Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease) [J].
DeLeve, LD ;
Shulman, HM ;
McDonald, GB .
SEMINARS IN LIVER DISEASE, 2002, 22 (01) :27-41
[6]  
ESTEP JE, 1991, DRUG METAB DISPOS, V19, P135
[7]   Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells [J].
Lamé, MW ;
Jones, AD ;
Wilson, DW ;
Dunston, SK ;
Segall, HJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :29091-29099
[8]  
McCuskey RS, 1986, PHYS TECH, P247
[9]   VENOOCCLUSIVE DISEASE OF THE LIVER AND MULTIORGAN FAILURE AFTER BONE-MARROW TRANSPLANTATION - A COHORT STUDY OF 355 PATIENTS [J].
MCDONALD, GB ;
HINDS, MS ;
FISHER, LD ;
SCHOCH, HG ;
WOLFORD, JL ;
BANAJI, M ;
HARDIN, BJ ;
SHULMAN, HM ;
CLIFT, RA .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (04) :255-267
[10]   N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation [J].
Ringdén, O ;
Remberger, M ;
Lehmann, S ;
Hentschke, P ;
Mattsson, J ;
Klaesson, S ;
Aschan, J .
BONE MARROW TRANSPLANTATION, 2000, 25 (09) :993-996